Search Results - Matt Wasserman

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Review of vaccine effectiveness assumptions used in economic evaluations of infant pneumococcal conjugate vaccine by Matt Wasserman, Heather L Sings, Dylan Jones, Sarah Pugh, Margaret Moffatt, Raymond Farkouh

    Published in Expert Review of Vaccines (2018-01-01)
    Get full text
    Article


  2. 2

    Cost-Effectiveness of the Pneumococcal Conjugate Vaccine (10- or 13-Valent) Versus No Vaccination for a National Immunization Program in Tunisia or Algeria by Sarah J. Pugh, Mark A. Fletcher, Apostolos Charos, Lynda Imekraz, Matt Wasserman, Raymond Farkouh

    Published in Infectious Diseases and Therapy (2018-12-01)
    Get full text
    Article


  3. 3

    Comment on Gomez et. al. “Response to article by Wasserman et. al. (2018) ‘Modelling the sustained use of the 13-valent pneumococcal conjugate vaccine compared to switching to the... by Matt Wasserman, Maria Gabriela Palacios, Ana Gabriela Grajales, Michele Wilson, Cheryl McDade, Raymond Farkouh

    Published in Human Vaccines & Immunotherapeutics (2019-03-01)
    Get full text
    Article


  4. 4

    Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants by Johnna Perdrizet, Carlos Felipe S. Santana, Thais Senna, Rodrigo Fernandes Alexandre, Rodrigo Sini de Almeida, Julia Spinardi, Matt Wasserman

    Published in Human Vaccines & Immunotherapeutics (2021-04-01)
    Get full text
    Article


  5. 5

    Cost-utility and cost-benefit analysis of pediatric PCV programs in Egypt by JP Sevilla, Daria Burnes, Rehab Zakaria El Saie, Hammam Haridy, Matt Wasserman, Sarah Pugh, Johnna Perdrizet, David Bloom

    Published in Human Vaccines & Immunotherapeutics (2022-11-01)
    Get full text
    Article


  6. 6

    A systematic literature review of economic evaluations of pneumococcal conjugate vaccines in east and southeast Asia (2006-2019) by Bruce Cm Wang, Nathorn Chaiyakunapruk, Shuiqing Zhu, Joseph B. Babigumira, Wesley Furnback, Ramaa Chitale, Amgad Gamil, Kun Zhao, Matt Wasserman

    Published in Expert Review of Vaccines (2022-07-01)
    Get full text
    Article


  7. 7

    Estimating the Impact of Switching from a Lower to Higher Valent Pneumococcal Conjugate Vaccine in Colombia, Finland, and The Netherlands: A Cost-Effectiveness Analysis by Sarah Pugh, Matt Wasserman, Margaret Moffatt, Susana Marques, Juan Manuel Reyes, Victor A. Prieto, Davy Reijnders, Mark H. Rozenbaum, Juha Laine, Heidi Åhman, Raymond Farkouh

    Published in Infectious Diseases and Therapy (2020-02-01)
    Get full text
    Article


Search Tools: